No Data
No Data
Pulmonx Corporation's (NASDAQ:LUNG) 29% Jump Shows Its Popularity With Investors
Pulmonx Corporation (NASDAQ:LUNG) shareholders are no doubt pleased to see that the share price has bounced 29% in the last month, although it is still struggling to make up recently lost ground.
Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024
Pulmonx(LUNG.US) Officer Sells US$7,293.44 in Common Stock
$Pulmonx(LUNG.US)$ Officer Rose Geoffrey Beran sold 1,184 shares of common stock on Jun 24, 2024 at an average price of $6.16 for a total value of $7,293.44.Source: Announcement What is statement of c
Pulmonx Initiated at Buy by Lake Street
Pulmonx Initiated at Buy by Lake Street
Lake Street Initiates Pulmonx(LUNG.US) With Buy Rating, Announces Target Price $12
Lake Street analyst Frank Takkinen initiates coverage on $Pulmonx(LUNG.US)$ with a buy rating, and sets the target price at $12.According to TipRanks data, the analyst has a success rate of 34.2% and
Why We're Not Concerned About Pulmonx Corporation's (NASDAQ:LUNG) Share Price
With a price-to-sales (or "P/S") ratio of 4x Pulmonx Corporation (NASDAQ:LUNG) may be sending bearish signals at the moment, given that almost half of all Medical Equipment companies in the United Sta